Is NNVC or NSRX more undervalued in 2026?

CirclFi compares NanoViricides, Inc. (NNVC) and Nasus Pharma Ltd. (NSRX) using 13 institutional-grade valuation models. NNVC has a Quality of Company score of 4.3/10 while NSRX scores 1.9/10.

Which is a better buy — NNVC or NSRX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NNVC and NSRX valuations compare?

NNVC at $1.78 and NSRX at $3.36 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NNVC vs NSRX Valuation Comparison 2026 — Intrinsic Value Analysis

NNVC

Pharmaceutical Preparations

NanoViricides, Inc.

Quality

4.3

out of 10

Value Trap

LOW

Price

$1.78

Last close

Models

7/13

Active

NSRX

Pharmaceutical Preparations

Nasus Pharma Ltd.

Quality

1.9

out of 10

Value Trap

—

Price

$3.36

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	NNVC Fair Value	NNVC Upside	NSRX Fair Value	NSRX Upside
Bayesian DCF	Intrinsic	$0.48	-73.1%	$0.78	-76.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.00	-43.9%	$0.15	-95.4%
PWERM	Option-Based	$1.47	-17.7%	$2.27	-32.4%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NNVC vs NSRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NNVC vs NSRX — Which Stock Is More Undervalued?

NNVC scores higher with a 4.3/10 quality rating vs NSRX's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing NanoViricides, Inc. (NNVC) and Nasus Pharma Ltd. (NSRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NNVC currently trades at $1.78 with a QOC of 4.3/10, while NSRX trades at $3.36 with a QOC of 1.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).